IDT Australia has the experience, expertise and the technology to manage all of your drug development and commercial production requirements.

Our pharmaceutical manufacturing capabilities include:
An audited and accredited 12,000m² site in Melbourne, Australia.
A modular campus, designed to accommodate R&D activities through to commercial-scale API and FDF formulation and manufacture.
Expertise in the synthesis of small molecules at up to 4,000L scale; as well as acellular processing on RNA products.
We can formulate and manufacture a range of FDF products, (tablets, capsules, lyophilized and sterile fill/finish) in accordance with ICH guidance under full cGMP.
Our site is audited and accredited by the Australian Therapeutic Goods Administration, European Medicines Agency and the U.S. Food and Drug Administration.
Our manufacturing facilities are supported by in-house analytical method development, stability chambers, modern chemistry and microbiology quality control laboratories, and a robust quality assurance system.

We have immediate capacity to start on any projects you currently have, or future projects and we are continuing to build our capability in areas such as linker synthesis, payload sourcing, bioconjugation, purification, and fill finish at all stages of the product development lifecycle.

If this is of interest to you, I would be delighted to schedule a call at your convenience to discuss collaboration opportunities in more detail.